.png){kind=icon}
.png){kind=icon}
Return
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
.png){kind=icon}
OA
AI
A
P
K
D
R
H
P
A
D
P
DOI：10.1111/bph.70493.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Autosomal dominant polycystic kidney disease (ADPKD) is a leading cause of end-stage renal disease with limited treatment options. Drug repurposing offers a promising strategy to find effective treatments.
Keywords:
autosomal dominant polycystic kidney disease
drug repurposing
salicylic acid
target identification
thermal proteome profiling
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.7
Papers:
1.4W
Citations:
3.7W
Organization
Cited Papers